Literature DB >> 4193690

Selection of patients with pulmonary embolism for thrombolytic therapy.

V V Kakkar, E B Raftery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4193690     DOI： 10.1016/s0140-6736(70)92587-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Anticoagulant and thrombolytic drugs. II. Clinical aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 2.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism.

Authors:  D A Tibbutt; J A Davies; J A Anderson; E W Fletcher; J Hamill; J M Holt; M L Thomas; G Lee; G A Miller; A A Sharp; G C Sutton
Journal:  Br Med J       Date:  1974-03-02

Review 4.  Pulmonary embolism--the role of thrombolytic therapy in its management.

Authors:  R S More; A Chauhan
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.